Daniel Langendoerfer
Papers
1
Total Citations
42
H-Index
1
About
Daniel Langendoerfer is a leading figure in stem cell bioengineering, whose work centers on automating the production and analysis of human induced pluripotent stem cells (hiPSCs) to overcome critical bottlenecks in regenerative medicine. His most notable contribution is the development of the StemCellFactory, a modular, fully integrated robotic platform that enables the automated generation, expansion, and quality control of hiPSC lines. This system directly addresses the challenge of high phenotypic variability across cell lines by enabling the parallel production of large, standardized hiPSC cohorts—a prerequisite for robust disease modeling and drug screening. The StemCellFactory, detailed in his 2020 paper (42 citations), represents a paradigm shift from manual, error-prone processes to scalable, reproducible automation. Langendoerfer’s work has been instrumental in advancing the field toward high-throughput stem cell research, reducing human error and increasing experimental reproducibility. His achievements underscore a commitment to translating stem cell biology into practical, industrial-scale applications, making him a pivotal figure for students and researchers interested in the intersection of automation, bioengineering, and stem cell therapeutics.
Research Focus
Key Achievements
Top Papers
- 1